Barrett's esophagus: The long and the short of it

American Journal of Gastroenterology

Volumn 94, Issue 1, 1999, Pages 30-40

  Nandurkar, Sanjay ^a   Talley, Nicholas J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; BILE REFLUX; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; METAPLASIA; PROGNOSIS; RISK FACTORS;

EID: 0032895257     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.00768.x     Document Type: Review

References (83)

1. Barrett N.R. Chronic peptic ulcer of the oesophagus and "oesophagitis." Br J Surg. 38:1950;175-182.
2. Weinstein W.M., Ippoliti A.F. The diagnosis of Barrett's esophagus Goblets, goblets, goblets . Gastrointest Endosc. 44:1996;91-95.
3. Spechler S.J., Goyal R.K. The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology. 110:1996;614-621.
4. Skinner D.B., Walther B.C., Riddell R.H., et al. Barrett's esophagus Comparison of benign and malignant cases . Ann Surg. 198:1983;554-566.
5. Igbal T.H., Neuman C.S., Cooper B.T. Omeprazole treatment of patients with Barrett's oesophagus. Gut. 34:(suppl):1993;S19.
6. Gore S., Healy C.J., Sutton R., et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther. 7:1993;623-628.
7. Spechler S.J., Zeroogian J.M., Antonioli D.A., et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 344:1994;1533-1536.
8. Nandurkar S., Talley N.J., Martin C.J., et al. Short segment Barrett's oesophagus Prevalence, diagnosis and associations . Gut. 40:1997;710-715.
9. Weston A.P., Krmpotich P., Makdisi W.F., et al. Short segment Barrett's esophagus Clinical and histological features associated endoscopic findings, and association with gastric intestinal metaplasia . Am J Gastroenterol. 91:1996;981-986.
10. Johnston M.H., Hammond A.S., Laskin W., et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol. 91:1996;1507-1511.
11. Morales T.G., Sampliner R.E., Bhattacharya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol. 92:1997;414-418.
12. Chalasani N., Wo J.M., Hunter J.G., et al. Significance of intestinal metaplasia in different areas of esophagus including esophagastric junction. Dig Dis Sci. 42:1997;603-607.
13. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci. 42:1997;597-602.
14. Trudgill N.J., Suvarna S.K., Kapur K.C., et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut. 41:1997;585-589.
15. Dias Pereira A., Suspiro A., Chaves P., et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagastric junctions The same or two different entities? Gut. 42:1998;659-662.
16. Goldblum J.R., Vicari J.J., Falk G.W., et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 114:1997;633-639.
17. Hackelsberger A., Gunther T., Schultze V., et al. Intestinal metaplasia at the gastro-oesophageal junction Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut. 43:1998;17-21.
18. Bozymski E.M. Barretts oesophagus: Endoscopic characteristics. Spechler S.J., Goyal R.K. Barrett's esophagus: Pathophysiology, diagnosis, and management. 1985;113-120 Elsevier, New York.
19. Kim S.L., Waring P., Spechler S.J., et al. Diagnostic inconsistencies in Barrett's esophagus. Gastroenterology. 107:1994;945-949.
20. Csendes A., Maluenda F., Braghetto I., et al. Location of lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut. 34:1993;21-27.
21. Weinstein W.M., Bogoch E.R., Bowes K.L. The normal human esophageal mucosa A histological reappraisal . Gastroenterology. 68:1975;40-44.
22. McClave S.A., Boyce H.W., Gottfried M.R. Early diagnosis of columnar-lined oesophagus A new endoscopic diagnostic criterion . Gastrointest Endosc. 33:1987;413-416.
23. Kahrilas P.J. Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am. 26:1997;467-486.
24. Spechler S.J. The columnar-lined esophagus. History, terminology, and clinical issues. Gastroenterol Clin North Am. 26:1997;455-466.
25. Hayward J. The lower end of the oesophagus. Thorax. 16:1961;36-41.
26. Paull A., Trier J.S., Dalton M.D., et al. The histologic spectrum of Barrett's esophagus. N Engl J Med. 295:1976;476-480.
27. Spechler S.J., Wang H.H., Chen Y.Y., et al. Inflammation of the gastric cardia and H. pylori infections are not risk factors for intestinal metaplasia at the esophagogastric junction. Gastroenterology. 112:1997;A297. (abstract).
28. Spechler S.J., Wang H.H., Chen Y.Y., et al. GERD versus H. pylori infections as potential causes of inflammation in the gastric cardia. Gastroenterology. 112:1997;A297. (abstract).
29. Hirota W.K., Loughney T.M., Lazas D.J., et al. The prevalence and demographics of specialized intestinal metaplasia at the esophagogastric junction in a cohort of 889 prospectively studied patients. Gastroenterology. 112:1997;A149. (abstract).
30. Hirota W.K., Loughney T.M., Lazas D.J., et al. Is Helicobacter pylori associated with specialized intestinal metaplasia of the esophagus or stomach? A prospective study of 889 patients. Gastroenterology. 112:1997;A149. (abstract).
31. Hirota W.K., Loughney T.M., Lazas D.J., et al. The prevalence, clinical characteristics and incidence of dysplasia in short segment Barrett's esophagus A prospective cohort of 889 patients . Gastroenterology. 112:1997;A577. (abstract).
32. Kuipers E.J., Uyterlinde A.M., Pena A.S., et al. Long term sequelae of Helicobacter pylori gastritis. Lancet. 345:1995;1525-1528.
33. Eidt S., Stolte M. Antral intestinal metaplasia in Helicobacter pylori gastritis. Digestion. 55:1994;13-28.
34. Gutierrez O., Sepulveda A.R., Genta R., et al. Intestinal metaplasia of Barrett's esophagus and its relation to intestinal metaplasia elsewhere in the stomach. Gastroenterology. 112:1997;A572. (abstract).
35. Logan R.P.H., Walker M.M., Misiewicz J.J., et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 36:1995;12-16.
36. Kim R., Baggott B.B., Rose S., et al. Quantitative endoscopy Precise computerized measurements of metaplastic epithelial surface area in Barrett's esophagus . Gastroenterology. 108:1995;360-366.
37. Kim R., Rose S., Shar A.O., et al. Extent of Barrett's-metaplasia - A prospective study of the serial change in area of Barrett's measured by quantitative endoscopy. Gastrointest Endosc. 45:1997;456-462.
38. Offner F.A., Weinstein W.M., Lewin K.J. Columnar non-goblet cell metaplasia A neglected feature in the diagnosis of Barrett's esophagus . Hum Pathol. 27:1996;885-889.
39. Spechler S.J., Zeroogian J.M., Wang H.H., et al. The frequency of specialized intestinal metaplasia at the squamo-columnar junction varies with the extent of columnar epithelium lining the esophagus. Gastroenterology. 108:1995;A224. (abstract).
40. Cameron A.J., Kamath P.S., Carpenter H.A. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology. 112:1997;A82. (abstract).
41. Reid B.J., Rubin C.E. When is the columnar-lined esophagus premalignant? Gastroenterology. 88:1985;1552.
42. Herlihy K.J., Orlando R.C., Bryson J.C., et al. Barrett's esophagus Clinical, histologic, manometric, and electrical potential difference characteristics . Gastroenterology. 86:1984;436-443.
43. Allison P.R., Johnstone A.S. The oesophagus lined with gastric mucous membrane. Thorax. 8:1953;87-101.
44. Rothery G.A., Patterson J.E., Stoddard C.J., et al. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus. Gut. 27:1986;1062-1068.
45. Peuchmaur M., Potet F., Goldfain D. Mucin histochemistry of the columnar epithelium of the esophagus (Barrett's esophagus) A prospective biopsy study . J Clin Pathol. 37:1984;607-610.
46. Cooper J.E., Spitz L., Wilkins B.M. Barrett's oesophagus in children. A histologic and histochemical study of 11 cases. J Paed Surg. 3:1987;191-196.
47. Fennerty M.B. Tissue staining. Gastrointest Endosc Clin North Am. 4:1994;297-311.
48. Canto M.I.F., Setrakian S., Petras R.E., et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 44:1996;1-7.
49. Krishnamurthy S., Dayal Y. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study. Am J Surg Pathol. 19:1995;1172-1180.
50. Stachura J., Konturek J.W., Urbanczyk K., et al. Endoscopic and histologic appearence of pancreatic metaplasia in the human gastric mucosa A priliminary report on a recently recognozed new type of gastric mucosal metaplasia . Euro J Gastroenterol Hepatol. 8:1996;239-243.
51. Wang H.H., Zeroogian J.M., Spechler S.J., et al. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol. 20:1996;1507-1510.
52. Shields H.M., Zwas F., Antonioli D.A., et al. Detection by electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium. Dig Dis Sci. 38:1993;97-108.
53. Sawhney R.A., Shields H.M., Allan C.H., et al. Morphological characterizations of the squamocolumnar junction of the esophagus in patients with and without Barrett's epithelium. Dig Dis Sci. 41:1996;1088-1098.
54. Das KM Sakamaki S., Vecchi M., et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis Cellular localization of the antigen by using monoclonal antibody . J Immunol. 139:1987;77-84.
55. Das KM Prasad I., Garla S., et al. Detection of shared colonic epithelial epitope on Barrett's epithelium by a novel monoclonal antibody. Ann Intern Med. 120:1994;753-756.
56. Griffel L.H., Weston A.P., Nandiwada K., et al. Diagnosis of short segment Barrett's esophagus (SSBE) using an immunohistochemical marker. Gastroenterology. 112:1997;A571. (abstract).
57. Garewal H.S., Morales T.G., Sampliner R.E., et al. Differentiation of gastric intestinal metaplasia at the cardia using an immunohistochemical marker An interinstitutional blinded study . Gastroenterology. 112:1997;A567. (abstract).
58. Cooper B.T., Cox M.A., Gearty J.C. Prevalence of specialised columnar epithelium at the cardia of patients with gastro-oesophageal disease without obvious Barrett's oesophagus; comparison with normal controls. Gut. 40:(suppl 1):1997;A143. (abstract).
59. Abo S.R., Stevens P.D., Abedi M., et al. Prevalence of short segment Barrett's epithelium in patients with gastroesophageal disease. Gastroenterology. 108:1995;A43. (abstract).
60. Klauser A.G., Schindlbeck N.E., Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet. 335:1990;205-208.
61. Schindlbeck N.E., Wiebecke B., Klauser A.G., et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut. 39:1996;151-154.
62. Clark G.W.B., Ireland A.P., Peters J.H., et al. Short segment Barrett's esophagus A prevalent complication of gastroesophageal reflux disease with malignant potential . J Gastrointest Surg. 1:1997;113-122.
63. Riddell R.H. The biopsy diagnosis of gastro esophageal reflux disease, "carditis", and Barrett's esophagus, and sequelae of therapy. Am J Surg Path. 20:(suppl 1):1996;S31-S50.
64. Genta R.M., Huberman R.M., Graham D.Y. The gastric cardia in Helicobacter pylori Infection. Hum Pathol. 25:1994;915-919.
65. Clark G.W.B., Ireland A.P., Chandrasoma P., et al. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction A new marker for gastroesophageal reflux disease . Gastroenterology. 106:1994;A63. (abstract).
66. Oberg S., Peters J.H., DeMeester T.R., et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 226:1997;522-532.
67. Cameron A.J., Lomboy C.T. Barrett's esophagus Age, prevalence, and extent of columnar epithelium . Gastroenterology. 103:1992;1241-1245.
68. Bremner C.G., Lynch V.P., Ellis F.H., et al. Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery. 68:1970;209-216.
69. Li H., Walsh T.N., O'Dowd G., et al. Mechanism of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery. 115:1994;176-181.
70. Hirota W.K., Loughney T.M., Lazas D.J., et al. Short segment Barrett's esophagus and specialized intestinal metaplasia at the esophagogastric junction Serial endoscopic and histologic assessment after acid suppression with omeprazole . Gastroenterology. 112:1997;A577. (abstract).
71. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
72. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 104:1993;510-513.
73. Nandurkar S., Talley N.J. Surveillance in Barrett's A need for reassessment? J Gastroenterol Hepatol. 13:1998;1069-1075.
74. Menkepluymers M.B.E., Hop W.C.J., Dees J., et al. Risk factors for the development of adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer. 72:1993;1155-1158.
75. Iftikhar S.Y., James P.D., Steele R.J.C., et al. Length of Barrett's oesophagus An important factor in the development of dysplasia and adenocarcinoma . Gut. 33:1992;1155-1158.
76. Schnell T.G., Sontag S.J., Chejfec G. Adenocarcinomas arising in tongues of short segments of Barrett's esophagus. Dig Dis Sci. 37:1992;137-143.
77. Nishimaki T., Watanabe K., Suzuki T., et al. Early esophageal adenocarcinoma arising in a short segment of Barrett's mucosa after total gastrectomy. Am J Gastroenterol. 9:1996;1856-1857.
78. Nandurkar S, Martin CJ, Talley NJ, et al. Curable cancer in a short segment Barrett's. Dis Esoph 1998 (in press).
79. Hamilton S.T., Smith R.R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma in Barrett's esophagus. Am J Clin Pathol. 87:1987;301-312.
80. Donahue D., Navab F. Significance of short segment Barrett's esophagus. J Clin Gastroenterol. 25:1997;480-484.
81. Sharma P., Morales T.G., Garewal H.S., et al. Dysplasia in short-segment Barrett's esophagus - a prospective 3-year follow up. Am J Gastroenterol. 92:1997;2012-2016.
82. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus Comparison with traditional long segment Barrett's esophagus . Am J Gastroenterol. 92:1997;407-413.
83. Grim I., Shaheen N., Bozymski E.M. Surveillance for Barrett's esophagus Are we saving lives? Gastroenterology. 112:1997;661-662.